PCD East Montgomery in Montgomery, Alabama - Dialysis Center

PCD East Montgomery is a medicare approved dialysis facility center in Montgomery, Alabama and it has 13 dialysis stations. It is located in Montgomery county at 6890 Winton Blount Blvd, Montgomery, AL, 36117. You can reach out to the office of PCD East Montgomery at (334) 260-0671. This dialysis clinic is managed and/or owned by Davita. PCD East Montgomery has the following ownership type - Profit. It was first certified by medicare in June, 1995. The medicare id for this facility is 012557 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NamePCD East Montgomery
Location6890 Winton Blount Blvd, Montgomery, Alabama
No. of Dialysis Stations 13
Medicare ID012557
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


6890 Winton Blount Blvd, Montgomery, Alabama, 36117
(334) 260-0671

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with PCD East Montgomery from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1447768601
Doing Business AsEast Montgomery Community Dialysis
Address6890 Winton Blount Blvd Montgomery, Alabama, 36117
Phone Number(610) 495-8900

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago


NPI Number1932163359
Organization NamePhysicians Choice Dialysis - East Montgomery
Doing Business AsPhysicians Choice Dialysis Of Alabama Llc
Address6890 Winton Blount Blvd Montgomery, Alabama, 36117
Phone Number(334) 260-0671

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data31
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL19

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center68
    Adult patient months included in Kt/V greater than or equal to 1.2591
    Percentage of adult patients getting regular hemodialysis at the center98
    Pediatic patients getting regular hemodialysis at the center1
    Pediatric patient months included in in Kt/V greater than or eqaul to 1.23
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    New research identifies cellular adaptive mechanisms during hypoxic conditions

    Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

    EU-funded health research project launches Horizon Health web portal

    The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

    Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

    Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

    GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

    GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

    Shire acquires 99.21% of Movetis shares

    Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at PCD East Montgomery with elevated calcium levels.

Patients with hypercalcemia72
Hypercalcemia patient months639
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor78
Patients with Serumphosphor less than 3.5 mg/dL13
Patients with Serumphosphor from 3.5 to 4.5 mg/dL25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL31
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL11

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 51
Patient months included in arterial venous fistula and catheter summaries 361
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment38
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer6

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary50
Hospitalization Rate in facility187.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit317.1
Hospitalization Rate: Lower Confidence Limit115.4

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at PCD East Montgomery were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility25.9 (As Expected)
Readmission Rate: Upper Confidence Limit38.3
Readmission Rate: Lower Confidence Limit16

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at PCD East Montgomery get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.83 (As Expected)
SIR: Upper Confidence Limit3.81
SIR: Lower Confidence Limit.74

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether PCD East Montgomery's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 47
Transfusion Rate in facility64.1 (As Expected)
Transfusion Rate: Upper Confidence Limit136.1
Transfusion Rate: Lower Confidence Limit33.1

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at PCD East Montgomery lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary284
Mortality Rate in facility11.6 (Better than Expected)
Mortality Rate: Upper Confidence Limit17
Mortality Rate: Lower Confidence Limit7.6

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago


Dialysis Facility in Montgomery, AL

FMC Capitol City
Location: 255 S Jackson Street, Montgomery, Alabama, 36104
Phone: (334) 263-1028
PCD Montgomery
Location: 1001 Forest Avenue, Montgomery, Alabama, 36106
Phone: (334) 269-9416
PCD East Montgomery
Location: 6890 Winton Blount Blvd, Montgomery, Alabama, 36117
Phone: (334) 260-0671
DCI Montgomery
Location: 544 South Mcdonough Street, Montgomery, Alabama, 36104
Phone: (334) 265-9190
FKC Montgomery
Location: 1400 Narrow Lane Pkwy, Montgomery, Alabama, 36111
Phone: (334) 286-4011

News Archive

New research identifies cellular adaptive mechanisms during hypoxic conditions

Circadian rhythms are 24 hour cycles that are guided by exposure to alternating periods of day and night. These cycles affect biological activities in a variety of living organisms which are attuned to the circadian clock.

EU-funded health research project launches Horizon Health web portal

The Horizon Health web portal has been officially launched today by Professor Anne Glover, Chief Scientific Advisor, European Commission, in the presence of the communication representatives of leading research institutions in Europe.

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

Shire acquires 99.21% of Movetis shares

Shire plc, the global specialty biopharmaceutical company, announces that its wholly owned subsidiary Shire Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on October 12, 2010, following a successful tender offer launched in September 2010.

Read more Medical News

› Verified 3 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.